NCT03738072

Brief Summary

Patients with drug-refractory epilepsy sometimes need to be implanted with intracerebral electrodes in order to identify their seizure onset zone. During this procedure, direct electrical brain stimulations represent a standard clinical practice to assess seizure sensitivity and for functional mapping. This study aims at assessing if extending the range of stimulation frequencies of the usual clinical frequencies is of benefit for the definition of the seizure onset zone and hence for the presurgical planning.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Nov 2018Dec 2026

First Submitted

Initial submission to the registry

November 8, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

November 14, 2018

Completed
8.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

8.1 years

First QC Date

November 8, 2018

Last Update Submit

May 6, 2026

Conditions

Keywords

EpilepsyElectrical Brain stimulationNeurosurgerystereo-electro-encephalography (SEEG)

Outcome Measures

Primary Outcomes (1)

  • Comparison of the index of efficient stimulation between standard clinical stimulation condition and StiMic stimulation condition

    Comparison for each patient of the index of efficient stimulations (assessed as any stimulation having yielded an electrical or clinical effect over the total number of stimulations) for each condition (standard clinical stimulations condition vs research stimulations condition).

    22 days after implantation of electrode

Secondary Outcomes (4)

  • efficient stimulation for each frequency of stimulation

    22 days after implantation of electrode

  • efficient stimulation for each type of brain area stimulated

    22 days after implantation of electrode

  • percentage change in the neuronal discharge rate

    30 second after stimulation

  • percentage change in the neuronal discharge rate for stimic stimulation condition

    30 second after stimulation

Study Arms (1)

StiMic stimulation condition

EXPERIMENTAL

StiMic stimulation condition will be evaluate during stereo-electro-encephalography and this condition will be compare to standard stimulation condition

Diagnostic Test: StiMiC stimulation condition

Interventions

This new condition of stimulation of electrical Brain Stimulation will be evaluate to determine if this stimulation is more efficient that standard stimulation condition

StiMic stimulation condition

Eligibility Criteria

Age12 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all patients undergoing a stereo-electro-encephalography (SEEG), age 12 to 65 years old.

You may not qualify if:

  • usual excluding criteria for a SEEG.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Toulouse

Toulouse, 3100, France

RECRUITING

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Jonathan Curot, MD

    CHU of Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jonathan Curot, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2018

First Posted

November 13, 2018

Study Start

November 14, 2018

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations